Heterogeneity of engrafted bone-lining cells after systemic and local transplantation

The outcome of various osteoprogenitor-cell transplantation protocols was assessed using Col1a1-GFP reporter transgenic mice. The model requires the recipient mice to undergo lethal total body irradiation (TBI) followed by rescue with whole bone marrow. When the mice are rescued with total bone marr...

Full description

Saved in:
Bibliographic Details
Published inBlood Vol. 106; no. 10; pp. 3650 - 3657
Main Authors Wang, Liping, Liu, Yaling, Kalajzic, Zana, Jiang, Xi, Rowe, David W.
Format Journal Article
LanguageEnglish
Published Washington, DC Elsevier Inc 15.11.2005
The Americain Society of Hematology
2005 by The American Society of Hematology
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The outcome of various osteoprogenitor-cell transplantation protocols was assessed using Col1a1-GFP reporter transgenic mice. The model requires the recipient mice to undergo lethal total body irradiation (TBI) followed by rescue with whole bone marrow. When the mice are rescued with total bone marrow from a Col1a1-GFP transgenic mouse, green fluorescence protein (GFP)-positive donor cells can be observed on most endosteal and trabecular bone surfaces. Although the cells express an osteoblast-restricted GFP, they fail to progress to osteocytes, do not form a mineralized matrix, and do not generate bone nodules in vitro. However when calvarial progenitor cells derived from the same transgenic mice are injected into the bone marrow space, osteogenesis by the donor cells is observed. Using different GFP colors that distinguish the donor and recipient osteoblasts, commingling of the 2 cells types is observed along the mineralizing osteoblast surface as well as within the osteocyte population of the endosteal bone. Despite the ability of the injected progenitor cells to produce bone within the injected bone, they lack the ability to form mineralized bone nodules when explanted to primary osteoblast culture. These reagents and imaging protocols will be useful in evaluating other cells having a better progenitor potential than calvarial-derived stromal cells.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
The publication costs of this article were defrayed in part by page charge payment. Therefore, and solely to indicate this fact, this article is hereby marked “advertisement” in accordance with 18 U.S.C. section 1734.
Reprints: David W. Rowe, Department of Genetics and Developmental Biology, University of Connecticut Health Center, Farmington, CT 06030; e-mail: rowe@neuron.uchc.edu.
Supported by grants from the Public Health Department; National Institutes of Health (NIH) PO1-AR038933, P20 GM65764, and U01-DK63478; and the Michael Geisman Fellowship of the Osteogenesis Imperfecta Foundation (Z.K.).
Prepublished online as Blood First Edition Paper, August 4, 2005; DOI 10.1182/blood-2005-02-0582.
ISSN:0006-4971
1528-0020
DOI:10.1182/blood-2005-02-0582